Summary
In order to estimate the contribution of platelet-activating factor (PAF) to the formation of chronic subdural haematomas (CSH), we measured plasma PAF and anti-PAF antibody levels in head-injured patients with and without CSH and normal volunteers. Plasma PAF and anti-PAF IgG levels were higher in patients with CSH than in patients without CSH or in normal volunteers. Furthermore, plasma PAF and anti-PAF IgG levels increased in a time-dependent manner over the first 35 days following head injury. These data suggest that PAF may be involved in the generation of CSH.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Benveniste J, Henson PM, Cochrane CG (1972) Leukocyte-dependent histamine release from rabbit platelets. J Exp Med 136: 1356–1377
Bergstrom M, Ericson K, Levander B, Svendsen P, Larsson S (1977) Computed tomography of cranial subdural and epidural hematomas: variation of attenuation related to time and clinical events such as rebleeding. J Comput Assist Tomogr 1: 445–449
Bligh EG, Dyer WJ (1959) A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37: 911–917
Camussi G, Algietta M, Coda R, Bussolino F, Piacibello W, Tetta C (1981) Release of platelet-activating factor (PAF) and histamine. II. The cellular origin of human PAF: monocytes, polymorphonuclear neutrophils and basophils. Immunology 42: 191–199
Charp H, Mauco G, Simon MF, Benveniste J, Douste-Blazy L (1981) Biosynthetic labeling of platelet activating factor from radioactive acetate by stimulated platelets. Nature 289: 312–314
Fujisawa H, Ito H, Saito K, Ikeda K, Nitta H, Yamashita J (1991) Immunohistochemical localization of tissue-type plasminogen activator in the lining wall of chronic subdural hematoma. Surg Neurol 35: 441–445
Hanahan DJ, Weintraub ST (1985) Platelet-activating factor. Isolation, identification and assay. In: Glick D (ed) Method of biochemical analysis. Wiley, New York, pp 195–219
Hirashima Y, Kato R, Ohmori T, Nagahori T, Nishijima M, Endo S, Takaku A, Karasawa K (1993) The role of platelet-activating factor (PAF) in the development of chronic subdural hematoma. In: Nakamura N, Hashimoto T, Yasue M (eds) Recent advances in neurotraumatology. Springer, Tokyo, pp 61–64
Hirashima Y, Nagahori T, Nishijima M, Endo S, Takaku A, Nakagawa Y (1994) Analysis of plasma and hematoma lipids related to choline glycerophospholipid in patients with chronic subdural hematoma. Neuro Med Chir (Tokyo) 34: 131–135
Hirashima Y, Endo S, Kato R, Ohmori T, Nagahori T, Nishijima M, Karasawa K, Nojima S, Takaku A (1994) Platelet-activating factor (PAF) and the development of chronic subdural haematoma. Acta Neurochir (Wien) 129: 20–25
Kwak R, Takeuchi F, Yokoyama M, Sasaki T, Ohi M (1989) Process of evolution to chronic subdural hematoma (first report): a study with MRI and CT. CT Kenkyu 11: 571–578 (in Japanese)
Lee TG, Lenihan DJ, Malone B, Roddy LL, Wasserman SJ (1984) Increased biosynthesis of platelet-activating factor in activated human eosinophils. 259: 5526–5530
Mencia-Huerta MJ, Benveniste J (1979) Platelet-activating factor and macrophages. I. Evidence for the release from rat and mouse peritoneal macrophages and not from mastocytes. Eur J Immunol 9: 409–415
Oda M, Satouchi K, Yasunaga K, Saito K (1985) Molecular species of platelet-activating factor generated by human neutrophils challenged with ionophore A 23187. J Immunol 134: 1090–1093
Prescott SM, Zimmerman GA, McIntyre TM (1984) Human endothelial cells in culture procedure platelet-activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) when stimulated with thrombin. Proc Natl Acad Sci USA 81: 3534–3538
Rosengren S, Bjork J, Smedegard G (1988) Oxygen radicals are not a prerequisite for neutrophil-mediated increased vascular permeability. Lab Invest 58: 559–564
Shaw JO, Pinckard RN, Ferrigni KS, McManus LM, Hanahan DJ (1981) Activation of human neutrophils with 1-0-hexadecyl/octadecyl-2-acetyl-sn-glyceryl-3-phosphorylcholine (platelet activating factor). J Immunol 127: 1250–1255
Tamura N, Agrawal DK, Suliaman FA, Townley RG (1987) Effects of platelet activating factor on the chemotaxis or normodense eosinophils from normal subjects. Biochem Biophys Res Commun 142: 638–644
Trotter W (1914) Chronic subdural hemorrhage of traumatic origin, and its relation to pachymeningitis hemorrhagica interna. Br J Surg 2: 271–291
Virchow R (1857) Das Haematoma der Durameter. Verhandlungen der physikalisch-medizinsichen Gesellschaft zu Würzburg 7: 134–142
Wardlaw AJ, Mogbel R, Cromwell O, Kay AB (1986) Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils. J Clin Invest 78: 1701–1706
Yamada H, Watanabe T, Murata S, Shibui S, Nihei H, Kohno T, Ito T (1980) Developmental process of chronic subdural collections of fluid based on CT scan findings. Surg Neurol 13: 441–448
Yamashima T, Kubota T, Yamamoto S (1985) Eosinophil degranulation in the capsule of chronic subdural hematomas. J Neurosurg 62: 257–260
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hirashima, Y., Endo, S., Hayashi, N. et al. Platelet-activating factor (PAF) and the formation of chronic subdural haematoma. Acta neurochir 137, 15–18 (1995). https://doi.org/10.1007/BF02188773
Issue Date:
DOI: https://doi.org/10.1007/BF02188773